Ny mjukvara ger dig full koll på dina massflödesprodukter

Håll koll på flödet med Windows-baserad mjukvara från Brooks.

She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a wel...

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Hello Jenni Nordborg!

Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.

Marie Gårdmark: Potential step change – EU regulators get to play with data

A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approva...

Carl Borrebaeck – professor and serial entrepreneur with a taste for speed

Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...

Startup-bolaget vill bli nästa Olink

Inte ens ett år gamla har Rarity Bioscience fått anslag från Swelife och Medtech4health. Nu hoppas vd:n Linus Bosaeus att deras teknik för detektion av mutation...

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

Study: An objective diagnosis of constant tinnitus may be possible

A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tin...

Han blir Addlifes nya vd

Efter att Addlifes nuvarande vd Kristina Willgård meddelat att hon ska avgå under året, har nu styrelsen rekryterat en ny verkställande direktör och koncernchef för företaget.

“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Norrländsk life science går för högtryck

Pharma Outsourcing igång på Stockholm Waterfront

Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Naturvetarna: Två miljoner kan få vänta på provsvar

Naturvetarna varnar för att Sverige inte bara har en vårdskuld efter pandemin, utan även en diagnostikskuld. Två miljoner människor kan få vänta på provsvar eft...

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

17 nätdroger narkotikaklassas

Vissa har orsakat dödsfall.

Pengaregn över hälsoprojekt

22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...

Addlifes vd Kristina Willgård: "Det har blivit en otroligt fin resa"

På drygt fem år har Addlife förvärvat ett 30-tal företag inom medicinteknik och life science – och bolaget fortsätter att växa. – Vi letar ständigt efter fina b...

Drug development creates new challenges for regulators